Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk

TY - JOUR

T1 - Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk

AU - The Korean Transient Elastography Study Group

AU - Kim, David Sooik

AU - Kim, Beom Kyung

AU - Seo, Yeon Seok

AU - Kim, Byung Seok

AU - Jang, Byoung Kuk

AU - Kim, Sang Gyune

AU - Suk, Ki Tae

AU - Lee, Jin Woo

AU - Jeong, Soung Won

AU - Kim, Seung Up

N1 - Funding Information: This study was supported by the Technology Innovation Program (20013712) funded by the Ministry of Trade, Industry, and Energy (MOTIE, Korea). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.

PY - 2022/8

Y1 - 2022/8

UR - http://www.scopus.com/inward/record.url?scp=85131539651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131539651&partnerID=8YFLogxK

U2 - 10.1111/liv.15282

DO - 10.1111/liv.15282

M3 - Letter

C2 - 35474279

AN - SCOPUS:85131539651

SN - 1478-3223

VL - 42

SP - 1902

EP - 1906

JO - Liver International

JF - Liver International

IS - 8

ER -